Butrans

Active Ingredient(s): Buprenorphine
FDA Approved: * June 30, 2010
Pharm Company: * PURDUE PHARMA LP
Category: Opioid Dependence

Buprenorphine/naloxone, sold under the brand name Suboxone among others, is a fixed-dose combination medication that includes buprenorphine and naloxone.[2] It is used to treat opioid use disorder, and reduces the mortality of opioid use disorder by 50% (namely by reducing the risk of overdose on full-agonist opioids such as heroin or fentanyl).[2][4][5] It relieves cravings to use and withdrawal symptoms.[6] Bupr... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
59 Discussions